Cargando…

Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials : proceedings of a workshop /

Even as the U.S. population becomes steadily more diverse, minorities and women remain underrepresented in clinical trials to develop new drugs and medical devices. Although progress in increasing minority participation in clinical trials has occurred, participation rates do not fully represent the...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Anderson, Karen M. (rapporteur.)
Autores Corporativos: National Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials (Workshop)
Otros Autores: Olson, Steve, 1956- (rapporteur.)
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Washington, DC : The National Academies Press, [2016]
Colección:Online access: NCBI NCBI Bookshelf.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_ocn957527254
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cn|||||||||
008 161004s2016 dcua obt 100 0 eng
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d MMU  |d CUS  |d YDX  |d EBLCP  |d N$T  |d OCLCF  |d OCLCO  |d MERUC  |d OCLCQ  |d OCLCO  |d OCLCA  |d BUF  |d EZ9  |d OCLCQ  |d WYU  |d NLM  |d OCLCO  |d VT2  |d OCLCA  |d OCL  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCO  |d OCLCA  |d AU@  |d LVT  |d OCLCO  |d OCLCA  |d K6U  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCA 
016 7 |a 101694023  |2 DNLM 
019 |a 958864695  |a 959425672  |a 961818374  |a 972011587  |a 1021264257  |a 1059035453  |a 1138965057  |a 1229437970  |a 1262689358 
020 |a 9780309443586 
020 |a 030944358X 
020 |z 9780309443579  |q (pbk.) 
020 |z 0309443571  |q (pbk.) 
024 7 |a 10.17226/23530  |2 doi 
029 0 |a NLM  |b 101694023 
029 1 |a AU@  |b 000058881421 
035 |a (OCoLC)957527254  |z (OCoLC)958864695  |z (OCoLC)959425672  |z (OCoLC)961818374  |z (OCoLC)972011587  |z (OCoLC)1021264257  |z (OCoLC)1059035453  |z (OCoLC)1138965057  |z (OCoLC)1229437970  |z (OCoLC)1262689358 
042 |a pcc 
043 |a n-us--- 
050 4 |a R853.C55 
060 0 0 |a 2016 I-594 
060 1 0 |a W 20.55.C5 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.84982 
049 |a UAMI 
100 1 |a Anderson, Karen M.,  |e rapporteur. 
245 1 0 |a Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials :  |b proceedings of a workshop /  |c Karen M. Anderson and Steve Olson, rapporteurs ; Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, Board on Population Health and Public Health Practice, Health and Medicine Division ; the National Academies of Sciences, Engineering, Medicine. 
264 1 |a Washington, DC :  |b The National Academies Press,  |c [2016] 
300 |a 1 online resource (1 PDF file (xiii, 69 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 3 |a Even as the U.S. population becomes steadily more diverse, minorities and women remain underrepresented in clinical trials to develop new drugs and medical devices. Although progress in increasing minority participation in clinical trials has occurred, participation rates do not fully represent the overall population of minorities in the United States. This underrepresentation threatens the health of both these populations and the general population, since greater minority representation could reveal factors that affect health in all populations. Federal legislation has sought to increase the representation of minorities and women in clinical trials, but legislation by itself has not been sufficient to overcome the many barriers to greater participation. Only much broader changes will bring about the meaningful participation of all population groups in the clinical research needed to improve health. To examine the barriers to participation in clinical trials and ways of overcoming those barriers, the National Academies of Sciences, Engineering, and Medicine held a workshop in April 2015. This publication summarizes the presentations and discussions from the workshop. 
536 |a This activity was supported by the Aetna Foundation, Health Resources and Services Administration, Kaiser Permanente, The Kresge Foundation, Merck & Co., Inc., Methodist Health Ministries, and Office of Minority Health, U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. 
588 0 |a Online resource; title from PDF title page (viewed October 18, 2016). 
505 0 |a Introduction and highlights of the workshop -- Historical perspectives and context -- Scientific issues: clinically meaningful inclusion -- Recruitment and retention issues: patient, provider, institutional, and system barriers -- Potential best practices and policy options. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Clinical trials. 
650 0 |a Discrimination in medical care. 
650 0 |a Health services accessibility. 
650 0 |a Ethnic groups. 
650 0 |a Minorities. 
650 0 |a Women. 
650 1 2 |a Clinical Trials as Topic 
650 2 |a Health Services Accessibility 
650 2 2 |a Communication Barriers 
650 2 2 |a Ethnicity. 
650 2 2 |a Healthcare Disparities 
650 2 2 |a Minority Groups 
650 2 2 |a Patient Selection 
650 2 2 |a Women 
651 2 |a United States 
650 6 |a Études cliniques. 
650 6 |a Discrimination dans les soins médicaux. 
650 6 |a Services de santé  |x Accessibilité. 
650 6 |a Groupes ethniques. 
650 6 |a Minorités. 
650 6 |a Sélection de patients. 
650 6 |a Femmes. 
650 7 |a ethnic groups.  |2 aat 
650 7 |a minorities.  |2 aat 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Women.  |2 fast  |0 (OCoLC)fst01176568 
650 7 |a Minorities.  |2 fast  |0 (OCoLC)fst01023088 
650 7 |a Ethnic groups.  |2 fast  |0 (OCoLC)fst00915958 
650 7 |a Clinical trials.  |2 fast  |0 (OCoLC)fst00864429 
650 7 |a Discrimination in medical care.  |2 fast  |0 (OCoLC)fst00895105 
650 7 |a Health services accessibility.  |2 fast  |0 (OCoLC)fst00953278 
655 2 |a Congress 
655 7 |a Conference papers and proceedings.  |2 fast  |0 (OCoLC)fst01423772 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Olson, Steve,  |d 1956-  |e rapporteur. 
710 2 |a National Academies of Sciences, Engineering, and Medicine (U.S.).  |b Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities. 
710 2 |a National Academies of Sciences, Engineering, and Medicine (U.S.),  |e issuing body. 
711 2 |a Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials (Workshop)  |d (2015 :  |c Washington, D.C.) 
776 0 8 |i Print version:  |a Anderson, Karen M.  |t Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials.  |d Washington, D.C. : National Academies Press, 2016 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1355685  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36565665 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36618280 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4690555 
938 |a EBSCOhost  |b EBSC  |n 1355685 
938 |a YBP Library Services  |b YANK  |n 13173397 
994 |a 92  |b IZTAP